APA-referens (7:e uppl.)

Ma, W., Wu, Z., Zhao, T., Xia, Y., Qin, J., Tian, X., . . . Wu, X. (2025). Preclinical evaluation of AAV9-coSMN1 gene therapy for spinal muscular atrophy. Molecular Medicine, 31(1), 1. https://doi.org/10.1186/s10020-025-01207-4

Chicago-referens (17:e uppl.)

Ma, Wenhao, et al. "Preclinical Evaluation of AAV9-coSMN1 Gene Therapy for Spinal Muscular Atrophy." Molecular Medicine 31, no. 1 (2025): 1. https://doi.org/10.1186/s10020-025-01207-4.

MLA-referens (9:e uppl.)

Ma, Wenhao, et al. "Preclinical Evaluation of AAV9-coSMN1 Gene Therapy for Spinal Muscular Atrophy." Molecular Medicine, vol. 31, no. 1, 2025, p. 1, https://doi.org/10.1186/s10020-025-01207-4.